Biogen
BIIB
1,145 hedge funds and large institutions have $62.8B invested in Biogen in 2018 Q3 according to their latest regulatory filings, with 142 funds opening new positions, 345 increasing their positions, 467 reducing their positions, and 84 closing their positions.
69% more first-time investments, than exits
New positions opened: 142 | Existing positions closed: 84
21% more capital invested
Capital invested by funds: $51.9B → $62.8B (+$10.9B)
4% more funds holding
Funds holding: 1,097 → 1,145 (+48)
3.35% more ownership
Funds ownership: 84.82% → 88.17% (+3.3%)
0% more funds holding in top 10
Funds holding in top 10: 28 → 28 (0)
26% less repeat investments, than reductions
Existing positions increased: 345 | Existing positions reduced: 467
41% less call options, than puts
Call options by funds: $1.11B | Put options by funds: $1.88B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$710M |
| 2 |
VOYA Investment Management
Atlanta,
Georgia
|
+$284M |
| 3 |
JIM
Jupiter Investment Management
London,
United Kingdom
|
+$213M |
| 4 |
Renaissance Technologies
New York
|
+$181M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$163M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$372M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$353M |
| 3 |
Morgan Stanley
New York
|
-$267M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$245M |
| 5 |
ClearBridge Investments
New York
|
-$235M |
BIIB Hedge Fund Activity: Q3 2018 in Review
1,145 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Biogen (BIIB) for Q3 2018, worth a combined $62.8B — up 21% from $51.9B a quarter earlier.
Buyers outnumbered sellers: 142 funds opened new BIIB positions and 84 closed out — a net gain of 58 holders — while 345 added to existing stakes and 467 trimmed.
The largest buyer was Capital World Investors, adding an estimated $710M. The largest seller was Janus Henderson Group, cutting an estimated $372M.
- 1,145 institutional investors held Biogen (BIIB) as of Q3 2018, up from 1,097 in Q2 2018.
- Funds reported $62.8B of Biogen stock for Q3 2018, up 21% quarter-over-quarter.
- 142 funds opened new Biogen positions in Q3 2018 and 84 closed out, a net change of +58 holders.
- The largest Biogen buyer in Q3 2018 was Capital World Investors, an estimated $710M added.
- The largest Biogen seller in Q3 2018 was Janus Henderson Group, an estimated $372M sold.
Based on aggregated 13F filings for Q3 2018.